COMPARATIVE ANALYSIS OF CHROMOSOMAL ABERRATIONS IN CHILDREN WITH ACUTE LEUKEMIA
DOI:
https://doi.org/10.31082/1728-452X-2020-215-216-5-6-7-14Keywords:
acute leukemia, bone marrow, blast cells, karyotype, chromosomal aberrations, cytogenetic studyAbstract
ological substrate is the blast cell. Chromosomal and molecular genetic aberrations play a major role in the acute leukemia pathogenesis, determing the morphological, immunological and clinical features of the disease.
Our study was aimed to to analyze retrospectively the structure and frequency of chromosomal aberrations in children with initially diagnosed acute leukemia.
Material and methods. Medical histories retrospective analysis of children charged to oncohematology department of the «Scientific Center of Pediatrics and Pediatric Surgery» in Almaty for the period 2015 - 2017 was carried out. 310 histories with primary diagnosed acute leukemia were studied.
Results and discussion. Among 310 patients different chromosome aberrations were isolated in 158 patients (51%) during cytogenetic and molecular cytogenetic (in situ hybridization) studies of bone marrow blast cells. A normal karyotype was observed in 102 patients (33%).
Conclusion. The lymphoblastic variant of acute leukemia was determined in 75.5%, that indicates its leading role in AL structure among the children of different ages. AML was determined in 22.6% of all OL cases. The most frequent chromosomal rearrangement in ALL patients was blast cell chromosome hyperdiploidy (10,6%) and t(12;21)(p13;q22)/ETV6-RUNX1,which was detected in 37 (16%) patients. The most frequent AML abberation was t (8;21) (q22;q22)/RUNX1-RUNX1T1, identified in 15 (21.4%) patients.
References
Volkova SA, Borovkov NN. Osnovy klinicheskoy gematologii: uchebnoe posobie [Fundamentals of clinical Hematology: a training manual]. Nizhny Novgorod: Publishing House of the Nizhny Novgorod State Medical Academy; 2013. 400 p.
Vorobiev AI. Rukovodstvo po gematologii 1-3 tt.s prilozheniyami [Guide to hematology 1-3 vols. with applications]. Moscow: NEWDIAMED; 2007. 1275 p.
Mrózek K., Harper DP, Aplan PD. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Hematol Oncol Clin North Am. 2009;23(5):991-1010. DOI: 10.1016/j.hoc.2009.07.001
Prakash G, Kaur A, Malhotra P, Khadwal A, et al. Current role of genetics in hematologic malignancies. Indian J Hematol Blood Transfus. 2016; 32(1):18-31. DOI: 10.1007/s12288-015-0584-4
Fleishman EV, Sokova OI, Popa AV, Kalinina II, Konstantinova LN. Complex karyotype in acute myeloid leukemia in children. Klinicheskaya onkogematologiya = Clinical oncohematology. 2015;8(2):151-160 (In Russ.)
Yanming Zhang, Michelle Le Beau. Classification, cytogenetics, and molecular genetics in acute lymphoblastic leukemia/lymphoma Available from: https://www.uptodate.com/contents/cytogenetics-and-molecular-genetics-in-acute-lymphoblastic-leukemia
Ol'shanskaya YV, Domracheva EV. Chromosomnye perestroika pri ostryh leykozah [Chromosomal rearrangements in acute leukemia]. Moscow: MED press-inform; 2006. 112 p.
Zuhovitskaya EV, Fiyas AT. New approaches in the diagnosis and treatment of acute myeloid leukemia. J of The Grodno State Medical University. 2016;3:44-51. (In Russ.)
Jean McGowan-Jordan, Annet Simons, Michael Schmid, eds.ISCN 2016: An International System for Human Cytogenetic Nomenclature. Basel, Switzerland: S.Karger; 2016.
Rukavitsyn OA. Gematologiya. Natsional'noye rukovodstvo [Hematology. National leadership]. Moscow: GEOTAR-Media. 2019. 784 p.
Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised Fourth Edition. Lyon: IARC; 2017. P.109-145;167-176
Pogorelov VM, Kozinetz GI. Keys to Diagnosing Acute Leukemia. Gematologiya i transfuziologiya = Hematology and Transfusiology. 2008;5:27–31 (In Russ.)
Haferlach T, et al. Modern diagnostics in acute leukemias. Crit Rev Oncol Hematol.2005;56(2):223-234
Chessells JM, Richards SM, Bailey CC, Lilleyman JS, Eden OB. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. Br J Haematol. 1995;89(2):364-372. DOI: 10.1111/j.1365-2141.1995.tb03313.x
Zahm SH, Devesa SS. Childhood cancer: overview of incidence trends and environmental carcinogens. Environ Health Perspect. 1995;103 Suppl 6(Suppl 6):177-184. DOI: 10.1289/ehp.95103s6177
Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type.Cancer.1995;75(8):2186-2195. DOI: 10.1002/1097-0142(19950415)75:8<2186::aid-cncr2820750825>3.0.co;2-f
Viana MB, Cunha KC, Ramos G, Murao M. Leucemia mielóide aguda na criança: experiência de 15 anos em uma única instituição [Acute myeloid leukemia in childhood: 15-year experience in a single institution]. J Pediatr (Rio J). 2003;79(6):489-496
Imamura T, Iwamoto S, Kanai R, et al. Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study. Br J Haematol. 2012;159(2):204-210. DOI: 10.1111/bjh.12030
Betz BL. Acute myeloid leukemia diagnosis in the 21st century. Arch Pathol Lab Med. 2010;34(10):1427-1433
Bacher U, et al. Molecular genetics in acute myeloid leukemia. Curr Opin Oncol. 2010;22(6):646-655
Martinez-Climent JA. Molecular cytogenetics of childhood hematological malignancies. Leukemia. 1997;11(12):1999-2021.
DOI: 10.1038/sj.leu.2400842
Creutzig U, Zimmermann M, Ritter J, et al. Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trials. Leukemia. 2005;19(12):2030-2042. DOI: 10.1038/sj.leu.2403920
Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. Blood. 2012;120(16):3187-3205. DOI: 10.1182/blood-2012-03-362608
Pui CH, Carroll W, Meshinchi S, et al. Biology, risk stratification, and therapy of pediatric acute leukemias: an update. J Clin Oncol. 2011;29(5):551–65
Moghrabi A, Levy DE, Asselin B, et al. Results of the Dana-Farber cancer institute ALL consortium protocol 95-01 for children with acute lymphoblastic leukemia. Blood. 2007;109(3):896–904. DOI: 10.1182/blood-2006-06-027714
Moorman A, Ensor H, Richards S, et al. Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial. Lancet Oncol. 2010;11(5):429–38. DOI: 10.1016/S1470-2045(10)70066-8
Schmidt A. Molecular markers in hematology and oncology. Praxis. 2010;99(19):1143-1452
Dawidowska M, et al. Molecular methods for diagnostics and assessment of treatment effectiveness in modern pediatric hematooncology. Postepy Biochem. 2006;52(4):408-416
